IDO1 and neoplasm: Strikingly, IDO is also overexpressed by tumor cells, as well as tumor-associated fibroblasts, and mesenchymal stem cells (MSC); regardless of the source, IDO has been shown to profoundly inhibit NK-mediated cytokine production, expression of natural cytolytic receptors (NCRs), and tumor cell cytolysis.